MPD: Project measures / variables set: McMullan7 VO2_n

Project measures / variables set: McMullan7 VO2_n_end

ID, description, units	MPD:61611 VO2_n_end mean oxygen consumption after 4 wks of treatment, during night [mL/h] exercise study
Measures	• no exercise group • moderate intensity group • high intensity group
Data set, strains	McMullan7 CC 4 strains sex: both age: 8-10wks
Procedure	monitoring system
Comparison	control group vs. multiple treatment / dosage groups
Ontology mappings	VT:0002121 metabolism trait VT:0002338 pulmonary ventilation trait MA:0000327 respiratory system MP:0005288 abnormal oxygen consumption

Values Means Δ Means Z-scores

Graph Type Points Bars

Dimensions Width: × Height: px

Plot Options Hide Error Bars Strains on X-axis

ANOVA Summary

Factor	DF	Sum of squares	Mean sum of squares	F value	p-value (Pr>F)
group	2	33623.9589	16811.9795	0.112	0.8941
sex	1	12960107.2998	12960107.2998	86.3316	< 0.0001
strain	3	7299533.9352	2433177.9784	16.2082	< 0.0001
group:sex	2	174946.418	87473.209	0.5827	0.5593
group:strain	6	2071606.1703	345267.695	2.2999	0.0358
sex:strain	3	1620651.2358	540217.0786	3.5986	0.0144
group:sex:strain	6	400517.6825	66752.9471	0.4447	0.8483
Residuals	214	32125702.6918	150120.106

Q-Q normality assessment based on residuals

INDIVIDUAL MEASURES

Project	ID		Treatment	Measure / Variable Description	Panel	Strains tested	Sex	Age
McMullan7	61611	monitoring system	exercise	mean oxygen consumption after 4 wks of treatment, during night [mL/h] no exercise group VO2_n_end_ctrl	CC	4	both	8-10wks
McMullan7	61612	monitoring system	exercise	mean oxygen consumption after 4 wks of treatment, during night [mL/h] moderate intensity group VO2_n_end_MICT	CC	4	both	8-10wks
McMullan7	61613	monitoring system	exercise	mean oxygen consumption after 4 wks of treatment, during night [mL/h] high intensity group VO2_n_end_HIIT	CC	4	both	8-10wks